International
The Morning Science

What science found today

‹
 

Research

TLR5 drives metabolic dysfunction-associated steatohepatitis through lipid- and flagellin-induced hepatocyte injury signaling

Science · By Wenhao Li, Niannian Wang, Dania El Abyad, Seray Anak, Raju Kumar, Iris Ginés, Upkar Gill, Gillian Hood, James Brindley, Charles Mein, James Boot, Una Rose Wilcox, Neil Dufton, Robert Goldin, Tania Roskams, John Loy, Kalpana Devalia, Humza Malik, Adam Goralcyzk, Maria Jimenez-Ramos, Timothy J. Kendall, Jonathan A. Fallowfield, Maria Ines Castanho Martins, Krista Rombouts, Michele Vacca, Olivier Govaere & William Alazawi ·

The Brief

  • A study in Science Advances reports that TLR5 drives metabolic dysfunction-associated steatohepatitis (MASH).
  • The study describes lipid- and flagellin-induced hepatocyte injury signaling as the mechanism involved.
  • Only the title and citation were available, so experimental details and sample sizes are not known from the provided sources.

Why it matters

It links the immune receptor TLR5 to liver injury in MASH, a possible new target for future research, though the provided sources contain no experimental details.

Who’s affected

  • researchers studying liver disease and metabolic dysfunction
  • clinicians and drug developers interested in MASH

Science Advances, Volume 12, Issue 47 , November 2026.

Timeline

  1. Study published in Science Advances (Volume 12, Issue 47)

  2. science.org

    TLR5 drives metabolic dysfunction-associated steatohepatitis through lipid- and flagellin-induced hepatocyte injury signaling

How do you feel about this?

0 Comments

    TLR5 drives metabolic dysfunction-associated steatohepatitis through lipid- and flagellin-induced hepatocyte injury signaling – The Morning Science